相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
Yoshiyuki Suzuki et al.
CANCER RESEARCH (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Inhibition of Classic Signaling Is a Novel Function of Soluble Glycoprotein 130 (sgp130), Which Is Controlled by the Ratio of Interleukin 6 and Soluble Interleukin 6 Receptor
Christoph Garbers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Elevated Serum CRP Levels After Induction Chemoradiotherapy Reflect Poor Treatment Response in Association With IL-6 in Serum and Local Tumor Site in Patients With Advanced Esophageal Cancer
Hitoshi Fujiwara et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Inhibition of JAK2 Signaling by TG101209 Enhances Radiotherapy in Lung Cancer Models
Yunguang Sun et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Association of C-Reactive Protein Levels and Long-Term Survival after Neoadjuvant Therapy and Esophagectomy for Esophageal Cancer
Urs Zingg et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival
James M. Donahue et al.
ANNALS OF THORACIC SURGERY (2009)
Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling
Elena V. Efimova et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2009)
Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas
Satoru Kikuchi et al.
CLINICAL CANCER RESEARCH (2008)
Fruit and vegetable consumption and squamous cell carcinoma of the esophagus in Japan: The JPHC study
Taiki Yamaji et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
Min Kyoung Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781
Joel Tepper et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Chemoradiation in the management of Esophageal cancer
Lawrence Kleinberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier
Masahiro Seike et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
E1201: An Eastern Cooperative Oncology Group (ECOG) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/RT or irinotecan/cisplatin/RT in endoscopy with ultrasound (EUS) staged adenocarcinoma of the esophagus
L. Kleinberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
Possible detection of pancreatic cancer by plasma protein profiling
K Honda et al.
CANCER RESEARCH (2005)
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
BH Burmeister et al.
LANCET ONCOLOGY (2005)
Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
AC Berger et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer
K Honda et al.
GASTROENTEROLOGY (2005)
Preoperative chemoradiotherapy for oesophageal cancer:: a systematic review and meta-analysis
F Fiorica et al.
GUT (2004)
A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma
JL Lee et al.
ANNALS OF ONCOLOGY (2004)
Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways
CM Leu et al.
ONCOGENE (2003)
Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma
H Shimada et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
Treatment response and prognosis of patients after recurrence of esophageal cancer
H Shimada et al.
SURGERY (2003)
The use of chemoradiotherapy in oesophageal cancer
JI Geh
EUROPEAN JOURNAL OF CANCER (2002)
Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency
SH Jee et al.
ONCOGENE (2001)
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
SA Jones et al.
FASEB JOURNAL (2001)
分享论文
